1. Home
  2. PLPC vs HROW Comparison

PLPC vs HROW Comparison

Compare PLPC & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Preformed Line Products Company

PLPC

Preformed Line Products Company

HOLD

Current Price

$378.26

Market Cap

1.8B

Sector

Industrials

ML Signal

HOLD

HROW

Harrow Inc.

HOLD

Current Price

$39.44

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLPC
HROW
Founded
1947
1998
Country
United States
United States
Employees
N/A
373
Industry
Water Sewer Pipeline Comm & Power Line Construction
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
2001
N/A

Fundamental Metrics

Financial Performance
Metric
PLPC
HROW
Price
$378.26
$39.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
8
Target Price
$275.00
$69.86
AVG Volume (30 Days)
85.4K
540.4K
Earning Date
04-29-2026
05-11-2026
Dividend Yield
0.25%
N/A
EPS Growth
N/A
N/A
EPS
6.62
N/A
Revenue
N/A
N/A
Revenue This Year
$17.19
$31.62
Revenue Next Year
$7.28
$50.77
P/E Ratio
$54.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$151.11
$28.54
52 Week High
$414.35
$54.98

Technical Indicators

Market Signals
Indicator
PLPC
HROW
Relative Strength Index (RSI) N/A 45.85
Support Level N/A $37.03
Resistance Level N/A $41.82
Average True Range (ATR) 0.00 2.18
MACD 0.00 -0.53
Stochastic Oscillator 0.00 28.89

Price Performance

Historical Comparison
PLPC
HROW

About PLPC Preformed Line Products Company

Preformed Line Products Co is a designer and manufacturer of products and systems for constructing and maintaining overhead and underground networks for energy, telecommunication, cable operators, data communication, and other industries. The Company's primary products support, protect, connect, terminate, and secure cables and wires. The Company provides helical solutions, connectors, fiber optic and copper splice closures, solar framing applications, and electric vehicle charging station foundations. The Company's customers include public and private energy utilities and communication companies, cable operators, contractors and subcontractors, distributors, and value-added resellers. Geographically, the company operates in four regions: PLP-USA, the Americas, EMEA, and Asia-Pacific.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Share on Social Networks: